These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17212587)

  • 1. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.
    Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
    Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
    Sun Y; Connors KE; Yang DQ
    Mol Cell Biochem; 2007 Dec; 306(1-2):239-45. PubMed ID: 17786544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    Rattan R; Giri S; Singh AK; Singh I
    J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
    Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
    Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
    J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling.
    Su RY; Chao Y; Chen TY; Huang DY; Lin WW
    Mol Cancer Ther; 2007 May; 6(5):1562-71. PubMed ID: 17513605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
    Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
    J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells.
    Galardo MN; Riera MF; Pellizzari EH; Cigorraga SB; Meroni SB
    J Mol Endocrinol; 2007 Oct; 39(4):279-88. PubMed ID: 17909267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
    Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
    Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
    Zajkowicz A; Rusin M
    Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
    Woollhead AM; Scott JW; Hardie DG; Baines DL
    J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation.
    Favero CB; Mandell JW
    Brain Res; 2007 Sep; 1168():1-10. PubMed ID: 17706943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
    Perrin C; Knauf C; Burcelin R
    Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.